Skip to content

Health Coaching for Glaucoma Patients

Health Coaching for Glaucoma Patients, Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02090777
Enrollment
9
Registered
2014-03-18
Start date
2014-05-31
Completion date
2015-04-30
Last updated
2016-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

The study will be conducted to examine the feasibility of using a Health Coach for improving the ophthalmic care of glaucoma patients. Patients taking glaucoma medications will have a coaching intervention and adherence to glaucoma drops will be monitored using a dose-recording device. The dosing data will be analyzed to examine the effect on adherence and qualitative interviews at the conclusion of the study will be used to examine which elements of the coaching experience were most helpful in the glaucoma patient population.

Detailed description

Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage.

Interventions

BEHAVIORALHealth Coach

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult whose age is \>18 years * Diagnosed with glaucoma * Patient of Duke Glaucoma Service * Prescribed or using topical glaucoma eye medication for at least 6 months * Primarily self-administering his or her eye drops * English speaking * Patient should be able to use the telephone for the coaching intervention, * Patient should be available by phone to complete the coaching intervention * Patient should be willing and able to use the MEMS (Medication Event Monitoring System) device for recording medication use * Patient must be willing and able to come to the Eye Center for an exit interview and to return the MEMS device * Patient must be able to give consent

Exclusion criteria

* Patient should be excluded if he or she may need glaucoma surgery or laser during the 6 months of the study period

Design outcomes

Primary

MeasureTime frameDescription
Glaucoma Medication Adherence6 MonthsGlaucoma medication adherence will be tracked using a dose recording device to record eye drop usage. The average of the participants percentage of time they adhered to using the medication will be reported.

Countries

United States

Participant flow

Recruitment details

9 participants signed consent. 5 participants decided not to participate after signing consent and did not start study. 4 participants started and completed the study.

Participants by arm

ArmCount
Health Coach
Health Coach is conducted to see if it improves ophthalmic care for glaucoma patients. Health Coach
4
Total4

Baseline characteristics

CharacteristicHealth Coach
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
4 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age, Continuous73 years
Region of Enrollment
United States
4 participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 4
serious
Total, serious adverse events
0 / 4

Outcome results

Primary

Glaucoma Medication Adherence

Glaucoma medication adherence will be tracked using a dose recording device to record eye drop usage. The average of the participants percentage of time they adhered to using the medication will be reported.

Time frame: 6 Months

ArmMeasureValue (MEAN)Dispersion
Health CoachGlaucoma Medication Adherence72 percentage of adherence timeStandard Deviation 27

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026